(Q50617948)

16 March 2018

title

Opening Fronts in HIV Vaccine Development: Tracking the development of broadly neutralizing antibodies. (English)

1 reference

16 March 2018

author name string

Henning Gruell

series ordinal

1

1 reference

16 March 2018

Florian Klein

series ordinal

2

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 May 2014

1 reference

16 March 2018

published in

Nature Medicine

1 reference

16 March 2018

volume

20

1 reference

16 March 2018

issue

5

1 reference

16 March 2018

page(s)

478-479

1 reference

16 March 2018

Antibodies in HIV-1 vaccine development and therapy

cites work

1 reference

Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

21 January 2018

1 reference

Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop

21 January 2018

1 reference

Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization

21 January 2018

1 reference

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

21 January 2018

1 reference

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm

21 January 2018

1 reference

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

21 January 2018

1 reference

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

21 January 2018

1 reference

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

21 January 2018

1 reference

Shaping of human germline IgH repertoires revealed by deep sequencing

21 January 2018

1 reference

B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study

21 January 2018

1 reference

Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24804756

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24804756

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24804756

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.3567

1 reference

16 March 2018

1 reference

16 March 2018